jakarta28: ClinTex - New Medicine

PROBLEM AND SOLUTION

PROBLEM

Currently, efficiency issues in clinical trials are costing between $600,000 - $8m dollars per day, and are significantly delaying the delivery of new medicine to patients in need. We want to change that.

ClinTex are a solution provider to the pharmaceutical industry, and the team behind CTI - Clinical traials Interligence: a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use blockchain technology and smart contracts in clinical trials.

Our mission is to bring down the cost of medicine and improve the speed to the market of new medicines for the people who need them, through vastly reducing development cost for the global pharmaceutical industry.

SOLUTION

Clinical Trials Intelligence is a distributed technology platform that incorporates predictive data analytics, machine learning, and the innovative use of smart contracts to drive significant quality and operational improvements in clinical trials.

With the application of powerful and insightful data analytics functionality across administrative, operational and clinical functions, stakeholders can now indentify, action an resolve the potential issues detected before they negatively impact the trial.

Advanced workflow management, inclucling functionality and a blockchain based immutable audit trail.

Clinical Trials Intelligence has created an eco - system that fosters collaboration across the entire pharmaceutical industry while addressing the privacy and security concerns of all stakeholders.

PRESALE

CTI tokens in this round are priced at USD $0.05, which is a 50% discount on the main roud toke sale ( IEO) price, which will be USD $0.10.

The total amount of CTI tokens to be minted is 200,000,000

The total amount of CTI that will be sold (at USD 0.05) in the pre sale round is 20.000,000 (105 of the total minted)

The total amount of CTI that willbe sold at USD 0.1 in the main public sale round (IEO) is 60,0000,000 (30% of the total minted)

ROADMAP